Physician Wealth Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Physician Wealth Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$416	Buy	+338	New	+$540	﹤0.01%	2349

Other funds holding ALDX

Woodstock Corp Boston, Massachusetts $1.24B AUM 22.02% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.68B AUM 22.33% 1-Year Est. Return

Providence Wealth Advisors Frankfort, Illinois $174M AUM 29.13% 1-Year Est. Return

Hikari Power Tokyo, Japan $439M AUM 11.38% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Physician Wealth Advisors's ALDX Position: Q3 2026 in Review

Physician Wealth Advisors opened a new position in Aldeyra Therapeutics (ALDX) in Q3 2026: 338 shares worth $416. The stake represents ﹤0.01% of the portfolio and ranks #2349 among its holdings.

16 funds tracked by Wall St. Rank hold ALDX as of Q3 2026.

Physician Wealth Advisors held 338 shares of Aldeyra Therapeutics worth $416 as of Q3 2026.
Aldeyra Therapeutics was a new Physician Wealth Advisors position in Q3 2026.
Aldeyra Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #2349 holding.
16 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.